Invicta Diagnostic (INVICTA) Stock Overview

Owns and operates diagnostic centers under the PC Diagnostics brand name in India. More details

INVICTA fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (24.9x) is below the Indian market (25.6x)

Earnings grew by 30% over the past year

Risk Analysis

Shares are highly illiquid

Profit margins (16.2%) are lower than last year (23.7%)

Does not have a meaningful market cap (₹1B)

Does not have meaningful revenue (₹302M)

INVICTA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Invicta Diagnostic Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Invicta Diagnostic
Historical stock prices
Current Share Price	₹96.70
52 Week High	₹105.00
52 Week Low	₹95.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	13.76%

Recent updates

Shareholder Returns

	INVICTA	IN Healthcare	IN Market
7D	n/a	-3.9%	-2.3%
1Y	n/a	3.1%	-3.5%

Return vs Industry: Insufficient data to determine how INVICTA performed against the Indian Healthcare industry.

Return vs Market: Insufficient data to determine how INVICTA performed against the Indian Market.

Price Volatility

Is INVICTA's price volatile compared to industry and market?
INVICTA volatility
INVICTA Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.6%
Market Average Movement	5.1%
10% most volatile stocks in IN Market	8.5%
10% least volatile stocks in IN Market	3.0%

Stable Share Price: INVICTA's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine INVICTA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2016	105	Konica Srivastava	www.pcdiagnostics.in

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access modes for tests reports.

Invicta Diagnostic Limited Fundamentals Summary

How do Invicta Diagnostic's earnings and revenue compare to its market cap?
INVICTA fundamental statistics
Market cap	₹1.22b
Earnings (TTM)	₹48.92m
Revenue (TTM)	₹301.81m

24.9x

P/E Ratio

4.0x

P/S Ratio

Is INVICTA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INVICTA income statement (TTM)
Revenue	₹301.81m
Cost of Revenue	₹23.63m
Gross Profit	₹278.18m
Other Expenses	₹229.27m
Earnings	₹48.92m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	3.89
Gross Margin	92.17%
Net Profit Margin	16.21%
Debt/Equity Ratio	26.0%

How did INVICTA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/08 07:25
End of Day Share Price	2025/12/08 00:00
Earnings	2025/03/31
Annual Earnings	2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Invicta Diagnostic Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Invicta Diagnostic LimitedNSEI:INVICTA Stock Report